2-mg Intravitreous Aflibercept Injection
DRCR.net Protocol AB
Phase 3 small_molecule completed
Quick answer
2-mg Intravitreous Aflibercept Injection for Proliferative Diabetic Retinopathy is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Proliferative Diabetic Retinopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed